Week 24 of ATLAS (n = 315) | Open-label extension (n = 288) | P value a | |
---|---|---|---|
Age, years | 42.2 ± 11.57 | 42.4 ± 11.65 | 0.848 |
Male, n (%) | 236 (74.9) | 219 (76.0) | 0.777 |
White, n (%) | 301 (95.6) | 276 (95.8) | 1.000 |
Disease duration, years | 10.9 ± 9.47 | 10.9 ± 9.43 | 0.953 |
BASDAI score, 0–10 cm | 6.3 ± 1.69 | 6.3 ± 1.70 | 0.997 |
BASFI score, 0–10 cm | 5.4 ± 2.21 | 5.4 ± 2.19 | 0.900 |
SF-36 PCS, 0–50 | 32.5 ± 7.98 | 32.4 ± 8.00 | 0.846 |
SF-36 MCS, 0–50 | 43.7 ± 11.57 | 44.0 ± 11.48 | 0.804 |
SF-36 domain scales | |||
Physical Function | 47.1 ± 22.08 | 46.8 ± 22.49 | 0.893 |
Role–Physical | 20.3 ± 30.02 | 20.9 ± 30.25 | 0.808 |
Bodily Pain | 55.9 ± 25.06 | 55.9 ± 25.08 | 0.979 |
General Health | 42.6 ± 19.82 | 42.6 ± 20.06 | 0.997 |
Vitality | 31.1 ± 16.12 | 30.9 ± 16.12 | 0.875 |
Social Function | 33.1 ± 17.49 | 32.9 ± 17.30 | 0.895 |
Role–Emotional | 54.4 ± 42.98 | 56.1 ± 42.90 | 0.641 |
Mental Health | 61.7 ± 19.19 | 61.8 ± 19.17 | 0.952 |
ASQOL, 0–18 | 10.3 ± 4.29 | 10.3 ± 4.29 | 0.945 |